CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 55 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,438 | -22.3% | 71,776 | 0.0% | 0.00% | – |
| Q2 2023 | $80,389 | -49.0% | 71,776 | -52.7% | 0.00% | -100.0% |
| Q1 2023 | $157,704 | +83785.1% | 151,638 | -9.5% | 0.00% | 0.0% |
| Q4 2022 | $188 | -100.0% | 167,582 | -59.2% | 0.00% | -50.0% |
| Q3 2022 | $464,000 | -58.3% | 410,691 | -45.7% | 0.00% | -50.0% |
| Q2 2022 | $1,112,000 | -46.9% | 756,200 | -17.2% | 0.00% | -33.3% |
| Q1 2022 | $2,093,000 | -53.4% | 913,789 | -44.1% | 0.01% | -53.8% |
| Q4 2021 | $4,495,000 | +3877.9% | 1,634,412 | +8559.6% | 0.01% | – |
| Q3 2021 | $113,000 | -62.3% | 18,874 | -84.4% | 0.00% | -100.0% |
| Q1 2021 | $300,000 | – | 121,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 3,917,622 | $7,365,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 54,092 | $102,000 | 0.06% |
| Carmignac Gestion | 1,937,608 | $3,643,000 | 0.05% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 91,824 | $173,000 | 0.03% |
| SIGNATUREFD, LLC | 121,351 | $228,000 | 0.01% |
| Tekla Capital Management LLC | 165,330 | $311,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 184,000 | $346,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 567,903 | $1,068,000 | 0.01% |
| Integrated Advisors Network LLC | 15,700 | $30,000 | 0.00% |
| WEDBUSH SECURITIES INC | 22,900 | $43,000 | 0.00% |